NEW YORK, March 22 – Nycomed Amersham is continuing with its plans to launch an initial public offering of shares in its subsidiary Amersham Pharmacia Biotech on the Nasdaq this spring, despite the downturn in the economy and a warning from competitor Applied Biosystems, the company said Thursday.

“As far as the IPO goes, we continue to work through the normal process with the SEC in filing our registration statement,” Tracy Cheung, vice president of investor relations at AP Biotech, told GenomeWeb.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.